Contribution of Sonication to the Identification of Megaprosthesis Infection in Culture Negative Oncologic Patient

Matias Leonardo Cullari1, Ignacio Fita1, Pablo Sarmiento1

  • 1Orthopedic Surgery British Hospital of Buenos AiresBuenos Aires, Argentina.

Insights

Sonication effectively detects prosthetic joint infections in osteosarcoma patients by disrupting bacterial biofilms. This method significantly improves bacterial recovery compared to traditional tissue cultures, aiding in diagnosis.

Area of Science:

  • Orthopedic Oncology
  • Infectious Diseases
  • Biotechnology

Background:

  • Osteosarcoma commonly affects long bones in young individuals, with increasing use of megaprostheses in treatment.
  • Prosthetic joint infections are a significant complication following oncological surgery, with biofilm-forming bacteria posing a challenge.
  • Biofilms protect bacteria, making them resistant to conventional antimicrobial therapies and diagnostic methods.

Observation:

  • A 12-year-old patient with a femoral osteosarcoma developed a post-surgical prosthetic infection.
  • Standard soft tissue cultures from the patient yielded negative results for bacterial growth.
  • Sonication, utilizing long wave ultrasound, was applied to the retrieved implant material.

Findings:

  • Sonication successfully disrupted the bacterial biofilm on the prosthetic material.
  • This disruption led to a significantly higher recovery of bacterial growth compared to conventional tissue culture.
  • The sonication method enabled the detection of the prosthetic joint infection despite negative soft tissue cultures.

Implications:

  • Sonication represents a promising adjunctive technique for diagnosing challenging prosthetic joint infections, especially in oncological cases.
  • Improved bacterial detection through sonication can lead to more timely and effective treatment strategies for patients with osteosarcoma and prosthetic infections.
  • This approach may enhance patient outcomes by enabling earlier identification and management of implant-associated infections, reducing morbidity.